Postoperative Endophthalmitis - Urgent Management

Key Points

• Any substantial postoperative decline in vision with vitritis, hypopyon, or severe intraocular inflammation should be treated as possible endophthalmitis until proven otherwise.
• Pain is common but not required, and waiting for severe pain can delay treatment.
• Obtain vitreous or aqueous cultures when feasible, but do not delay intravitreal antibiotics for laboratory confirmation.
• Empiric intravitreal vancomycin plus ceftazidime remains a standard broad-spectrum bacterial regimen.
• Systemic antibiotics alone are not adequate treatment for routine acute postoperative bacterial endophthalmitis.
• Immediate vitrectomy is strongly considered in severe disease, especially profound visual loss, dense vitritis, rapid progression, or retinal complications.
• Chronic or recurrent postoperative inflammation should raise concern for indolent organisms such as Cutibacterium acnes or fungal infection.
• Repeated examination is essential because retinal detachment, persistent infection, and treatment failure may emerge after initial therapy.

Algorithm

1. Recognize decreased postoperative vision, pain, hypopyon, vitritis, or disproportionate inflammation and contact ophthalmology immediately.
2. Document visual acuity, pupil examination, anterior segment findings, IOP when safe, and posterior segment visibility.
3. Use B-scan ultrasound when media opacity prevents fundus visualization.
4. Obtain vitreous or aqueous sample for microbiology without delaying treatment.
5. Inject intravitreal vancomycin plus ceftazidime for presumed bacterial disease unless a specific exposure changes the regimen.
6. Assess need for urgent pars plana vitrectomy based on visual status, virulence, vitreous opacity, retinal findings, and clinical progression.
7. Add topical anti-inflammatory and cycloplegic therapy under ophthalmology guidance after antimicrobial treatment is established.
8. Reassess closely and repeat intravitreal therapy, vitrectomy, or source-control surgery when the eye fails to improve.

Clinical Synopsis & Reasoning

Postoperative endophthalmitis is an intraocular infection involving the aqueous, vitreous, or both after cataract surgery, glaucoma surgery, vitrectomy, intravitreal procedures, or other intraocular operations. Acute postoperative bacterial disease commonly presents within days to several weeks with rapidly worsening visual acuity, ocular pain, redness, photophobia, hypopyon, fibrin, and vitritis. Pain can be mild or absent, so lack of severe pain does not safely exclude infection. The most important diagnostic distinction is between expected postoperative inflammation and true infectious endophthalmitis, because delay in intravitreal therapy can lead to irreversible retinal injury.

Examination begins with visual acuity, pupils, slit-lamp assessment, intraocular pressure when safe, and dilated fundus examination. Dense vitritis may prevent visualization of the retina. B-scan ultrasonography can identify vitreous debris, membranes, retinal detachment, choroidal detachment, or other posterior-segment pathology when the fundus cannot be seen. Aqueous or vitreous samples should be obtained for Gram stain, culture, and, when available, molecular testing, but sampling must not create a treatment delay. The differential includes sterile postoperative inflammation, retained lens material, toxic anterior-segment syndrome, severe uveitis, vitreous hemorrhage, and retinal detachment. Toxic anterior-segment syndrome generally begins very early after surgery, is usually confined to the anterior chamber, and often causes less vitreous inflammation than endophthalmitis.

Acute cases are most often caused by gram-positive skin flora such as coagulase-negative staphylococci, Staphylococcus aureus, streptococci, and Cutibacterium species, with gram-negative organisms less common but potentially fulminant. Delayed or chronic postoperative endophthalmitis can present with recurrent low-grade inflammation, especially after corticosteroid taper, and may be caused by Cutibacterium acnes or fungi. Management therefore depends on tempo, surgical history, host factors, and microbiology rather than one fixed regimen.

Treatment Strategy & Disposition

The central treatment is prompt intravitreal antimicrobial therapy because systemic antibiotics alone do not reliably achieve therapeutic vitreous concentrations for routine acute postoperative bacterial endophthalmitis. A common empiric combination is intravitreal vancomycin 1 mg/0.1 mL for gram-positive coverage plus ceftazidime 2.25 mg/0.1 mL for gram-negative coverage. These are administered by an ophthalmologist after or during vitreous sampling. Intravitreal amikacin is an alternative gram-negative agent but is less favored because of retinal toxicity risk. Fungal disease requires a different approach, often including intravitreal voriconazole or amphotericin B plus systemic therapy according to organism and source.

Pars plana vitrectomy removes infected vitreous, reduces organism and inflammatory burden, permits a larger diagnostic sample, and can address retinal complications. The classic Endophthalmitis Vitrectomy Study established an immediate vitrectomy benefit in postoperative cases presenting with only light perception vision, while modern small-gauge vitrectomy and changing microbiology have led many retina specialists to consider earlier surgery in additional severe presentations. The decision is individualized according to visual acuity, fundus visibility, virulence, response to initial injection, retinal status, and surgical resources. Eyes with rapidly progressive infection, poor view, retinal detachment, or deteriorating vision deserve a low threshold for operative management.

Topical corticosteroids and cycloplegics are commonly used after intravitreal antimicrobial coverage to control inflammation and pain under ophthalmology direction. Intravitreal dexamethasone is sometimes used as an adjunct but is not a substitute for antibiotics. Reassess closely within hours to a day according to severity. Persistent or worsening inflammation can require repeat intravitreal treatment, vitrectomy, or revision of the diagnosis and antimicrobial spectrum. Delayed cases related to an infected intraocular lens capsule may require capsulectomy and sometimes removal or exchange of the intraocular lens for definitive source control.

Epidemiology / Risk Factors

• Postoperative endophthalmitis is uncommon after modern cataract surgery but remains one of the most feared vision-threatening complications.
• Risk is influenced by wound integrity, surgical complications, ocular-surface flora, host factors, and the specific procedure performed.
• Coagulase-negative staphylococci remain common causes of acute postoperative bacterial infection.
• Indolent Cutibacterium acnes and fungal organisms are more important in delayed or chronic presentations.

Investigations

Clues to Diagnosis

Pharmacology

Prognosis / Complications

• Visual outcome depends strongly on presenting vision, organism virulence, treatment delay, retinal involvement, and response to therapy.
• Coagulase-negative staphylococcal infection often has a better prognosis than streptococcal, Bacillus, or virulent gram-negative infection.
• Prompt intravitreal therapy can preserve useful vision, whereas delayed treatment can lead to retinal necrosis, detachment, phthisis, or loss of the eye.
• Chronic cases can recover well when the persistent intraocular source is identified and removed.

Patient Education / Counseling

• Explain that this is an emergency because infection is inside the eye and topical drops alone cannot reliably treat it.
• Prepare the patient for intravitreal injection and possibly urgent vitrectomy on the same day.
• Explain that cultures may be negative even when the clinical diagnosis is correct and treatment should not wait for culture results.
• Advise strict adherence to follow-up because the eye can worsen rapidly after the first treatment.
• Provide urgent instructions for increasing pain, further visual loss, new flashes or curtain symptoms, fever, or increasing redness.

Notes

The practical emergency principle is that intravitreal therapy cannot be replaced by increasingly intensive topical drops. Once true endophthalmitis is suspected, the decisive steps are retina or ophthalmology involvement, intraocular sampling, and prompt intravitreal antibiotics. Treatment decisions should not wait for the culture because culture sensitivity is imperfect and visual tissue is being injured in real time.

The classic Endophthalmitis Vitrectomy Study remains important, but its surgical thresholds were developed before modern small-gauge vitrectomy and current procedural patterns. Contemporary retina practice therefore uses the trial as a foundation rather than an absolute boundary. Profound visual loss, dense vitritis, aggressive organisms, retinal complications, or failure after injection all strengthen the case for early vitrectomy.

References

1. American Academy of Ophthalmology: Endophthalmitis — Link
2. AAO: Managing Endophthalmitis After Intravitreal Injections — Link